Adacyte Therapeutics is a Medical Device company dedicated to improving patient outcomes and quality of life.
Adacyte Therapeutics is a Medical Device company dedicated to improving patient outcomes and quality of life.
Adacyte Therapeutics is a unique multinational company, founded in 2018, committed to the development and commercialization of innovative and holistic therapeutic solutions.
Adacyte Therapeutics was born out of a profound desire and responsibility to provide proven therapeutic alternatives for patients suffering from complex diseases.
Currently, we offer an alternative treatment for autoimmune diseases such as: Inflammatory Bowel Disease, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ocular Behçet’s Disease or Pustular Psoriasis, which is both effective and avoid the extremely undesirable side effects of existing drug therapies.
Granulocyte-Monocyte Apheresis (GMA) with Adacolumn® has continued to demonstrate both efficacy and safety in the treatment of these autoimmune diseases.
As no two patients are exactly the same, Adacolumn® provides a unique non-pharmacological and non-surgical approach to improve patient’s outcomes which takes into account the diversity of their needs.
Copyright 2020 © Adacyte Therapeutics | C/ Jesús Serra Santamans, 5, 08174 Sant Cugat del Vallès (Barcelona)
Legal Advice | Privacy Policy | Social Network Privacy Policy | Cookies Policy | EN-COR-0320001
